LA MARCA, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.433
AS - Asia 13.459
EU - Europa 10.334
SA - Sud America 2.115
Continente sconosciuto - Info sul continente non disponibili 460
AF - Africa 325
OC - Oceania 84
Totale 59.210
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.759
SG - Singapore 4.364
CN - Cina 2.816
GB - Regno Unito 2.797
IT - Italia 2.147
HK - Hong Kong 1.966
BR - Brasile 1.621
VN - Vietnam 1.533
SE - Svezia 1.126
DE - Germania 877
FI - Finlandia 790
BD - Bangladesh 770
UA - Ucraina 595
RU - Federazione Russa 511
TR - Turchia 425
FR - Francia 402
CA - Canada 366
IN - India 294
KR - Corea 253
BG - Bulgaria 244
ID - Indonesia 178
AR - Argentina 177
NL - Olanda 174
JP - Giappone 146
MX - Messico 141
ES - Italia 128
IQ - Iraq 112
ZA - Sudafrica 87
EC - Ecuador 75
PL - Polonia 71
PK - Pakistan 69
CO - Colombia 67
AU - Australia 64
RO - Romania 64
AE - Emirati Arabi Uniti 60
PH - Filippine 60
IR - Iran 52
MY - Malesia 51
VE - Venezuela 50
CL - Cile 48
IE - Irlanda 48
UZ - Uzbekistan 45
DZ - Algeria 42
MA - Marocco 42
LT - Lituania 39
BE - Belgio 37
CH - Svizzera 36
DK - Danimarca 35
CZ - Repubblica Ceca 33
KE - Kenya 33
AT - Austria 32
JM - Giamaica 32
CR - Costa Rica 30
EG - Egitto 30
PY - Paraguay 29
TW - Taiwan 29
SA - Arabia Saudita 28
TH - Thailandia 27
JO - Giordania 24
NP - Nepal 24
AL - Albania 20
TN - Tunisia 20
DO - Repubblica Dominicana 17
HN - Honduras 17
NZ - Nuova Zelanda 17
PE - Perù 17
AZ - Azerbaigian 16
BO - Bolivia 16
IL - Israele 16
KZ - Kazakistan 16
SC - Seychelles 16
HR - Croazia 15
NG - Nigeria 15
NO - Norvegia 14
LV - Lettonia 12
MD - Moldavia 12
NI - Nicaragua 12
PS - Palestinian Territory 12
GT - Guatemala 11
PT - Portogallo 11
UY - Uruguay 11
GR - Grecia 10
HU - Ungheria 10
PA - Panama 9
PR - Porto Rico 9
ET - Etiopia 8
OM - Oman 8
SI - Slovenia 8
SK - Slovacchia (Repubblica Slovacca) 8
BA - Bosnia-Erzegovina 7
EU - Europa 7
GH - Ghana 7
QA - Qatar 7
TT - Trinidad e Tobago 7
KW - Kuwait 6
LB - Libano 6
RS - Serbia 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
Totale 58.658
Salva come PNG Salva come JPEG
Città #
Fairfield 3.903
Ashburn 3.504
Singapore 2.723
Santa Clara 2.456
Hong Kong 1.917
Woodbridge 1.887
Southend 1.737
Houston 1.594
Seattle 1.482
Cambridge 1.307
Wilmington 1.174
Chandler 1.125
Jacksonville 907
San Jose 892
Ann Arbor 759
Dearborn 681
Helsinki 679
Nyköping 675
Beijing 637
Council Bluffs 632
London 625
Hefei 590
Ho Chi Minh City 494
Los Angeles 475
Modena 397
Chicago 381
The Dalles 375
New York 359
Hanoi 339
San Diego 292
Milan 241
Princeton 238
Sofia 235
Seoul 212
Izmir 207
Lauterbourg 194
Eugene 193
Dallas 186
Moscow 185
Boardman 178
Buffalo 177
Columbus 165
São Paulo 142
Shanghai 139
Rome 128
Bremen 119
Salt Lake City 113
Jakarta 112
Tokyo 102
Phoenix 95
Atlanta 90
Munich 87
Guangzhou 86
Bologna 80
Frankfurt am Main 78
Toronto 76
Da Nang 74
Tampa 71
Orem 69
Redwood City 68
Redondo Beach 65
Haiphong 64
Amsterdam 63
Montreal 62
Vancouver 59
San Francisco 58
Denver 57
Naples 52
Rio de Janeiro 50
Warsaw 49
Brooklyn 46
Chennai 45
Baghdad 44
Elk Grove Village 44
Dublin 43
Johannesburg 43
Mexico City 42
Winnipeg 41
Falls Church 40
Philadelphia 40
Norwalk 39
Tashkent 39
Biên Hòa 38
Stockholm 38
Fremont 37
Miano 37
Boston 34
Kilburn 34
Melbourne 34
Nanjing 34
Belo Horizonte 31
Iasi 31
Mumbai 31
Ankara 30
Florence 30
Newark 30
North Bergen 30
Brasília 29
Porto Alegre 29
Turin 29
Totale 40.809
Salva come PNG Salva come JPEG
Nome #
The complex relationship between female age and embryo euploidy 794
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial 658
Age-specific reference values for serum FSH and estradiol levels throughout the reproductive period 549
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). 519
Chronic endometritis in recurrent implantation failure: Use of prednisone and IVF outcome 518
Anti-Mullerian hormone (AMH): what do we still need to know? 483
LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling 449
The menstrual cycle regularization following d-chiro-inositol treatment in PCOS women: a retrospective study 448
MATER protein as substrate of PKCepsilon in human cumulus cells. 422
Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: An individual patient data approach 417
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice 405
Age-specific nomogram for the decline in antral follicle count throughout the reproductive period 375
Embryo quality and implantation rate in two different culture media: ISM1 versus Universal IVF Medium. 373
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 370
From a circle to a sphere: the ultrasound imaging of ovarian follicle with 2D and 3D technology 360
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria 358
Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles 357
Human ovarian tissue cryopreservation: effect of sucrose concentration on morphological features after thawing 350
Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? 347
Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium 347
A novel transnational fresh oocyte donation (TOD) program based on transport of frozen sperm and embryos 347
How Much Does AMH Really Vary in Normal Women? 345
FSHR polymorphism p.N680S mediates different responses to FSH in vitro 345
The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH 341
Reference values in ovarian response to controlled ovarian stimulation throughout the reproductive period 338
Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol 334
Adnexal torsion during pregnancy after oocyte in vitro maturation and intracytoplasmic sperminjection cycle 333
Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology 332
Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles 329
Pregnant woman infected by Coronavirus disease (COVID-19) and calcifications of the fetal bowel and gallbladder 328
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 327
Vitamin D and ovarian reserve: making clinical decisions 324
Nitric Oxide concentration in endometrial washing throughout the menstrual cycle 322
Elevated levels of nitrous dioxide are associated with lower AMH levels: A real-world analysis 322
Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization 317
Periodontal disease and nitric oxide levels in low risk women with preterm labor 315
Evidence for cycle-dependent expression of follicle-stimulating hormone receptor in human endometrium 315
Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome 313
Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study 311
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 309
Primary ovarian insufficiency: autoimmune causes. 304
The management of vaginal agenesis: report of 104 cases 304
The physiology and clinical utility of anti-Mullerian hormone in women 303
Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study 302
A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles 302
Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome 300
The anti-Müllerian hormone (AMH) induces forkhead box L2 (FOXL2) expression in primary culture of human granulosa cells in vitro 299
Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count 298
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction 297
New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation 297
Seminal plasma total antioxidant capacity and semen parameters in patients with varicocele 295
The FSHR polymorphism p.N680S mediates different response kinetics to FSH in vitro 293
Administration of L-thyroxine does not improve the response of the hypothalamo-pituitary-ovarian axis to clomiphene citrate in functional hypothalamic amenorrhea 292
Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome? 290
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI) 289
Hypothalamo-pituitary-adrenal axis and adrenal function before and after ovariectomy in premenopausal women 288
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival 288
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 286
Anti-Mullerian hormone concentrations in maternal serum during pregnancy 285
Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history 284
Adrenal adenocarcinoma and empty sella syndrome in a 37-year-old woman 283
Evaluation of the treatment with D-chiroinositol on levels of oxidative stress in PCOS patients 283
The use of ovarian reserve markers in IVF clinical practice: a national consensus 281
Gonadotrophins modulate cell death-related genes expression in human endometrium 279
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 278
Utero-vaginal anastomosis in the treatment of cervical atresia 276
The ovarian follicular pool and reproductive outcome in women. 275
Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: An individual patient data meta-analysis 274
Anti-mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause 270
Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation 269
Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes 268
Metformin treatment of PCOS during adolescence and the reproductive period 266
Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome 266
Rectus abdominis muscle endometriosis: Case report and review of the literature 265
Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata 265
How to personalize ovarian stimulation in clinical practice 264
Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction 260
8th World Congress of Gynecological Endocrinology 258
Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study 257
Rectovaginal fistula repair using fascia graft of autologous abdominal muscles 255
The negative impact of most relevant infections on fertility and Assisted Reproduction Technology 255
Serum anti-Mullerian hormone throughout the human menstrual cycle 254
Reply: The two sides of the individualization of controlled ovarian stimulation 253
The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age 253
Soluble L-selectin levels during controlled ovarian hyperstimulation 252
Thyroid function in early pregnancy II: Paradoxical growth hormone response to thyrotropin-releasing hormone 252
Anti-Müllerian hormone: clairvoyance or crystal clear? 250
Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia 248
Hormonal and ultrasound markers of ovarian function in a woman with a balanced 1;11 translocation 247
The journey from the old to the new AMH assay: how to avoid getting lost in the values 247
How adenomyosis changes throughout pregnancy: A retrospective cohort study 246
Recombinant LH administration in subsequent cycle after "unexpected" poor response to recombinant FSH monotherapy 245
Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency 245
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives 245
Gestrinone in the treatment of uterine leiomyomata: effects on uterine blood supply 244
External validation of anti-Müllerian hormone based prediction of live birth in assisted conception 244
Clinical, endocrine and metabolic effects of acarbose, an α-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance 244
Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women 244
Recombinant human leptin in women with hypothalamic amenorrhea. 241
Progestin effects on epidermal growth factor receptor (EGFR) endometrial expression in normal and hyperplastic endometrium 241
Totale 31.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 234.872
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.872
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.528 0 0 513 160 84 175 345 216 415 356 872 392
2022/20233.625 454 416 349 293 473 434 82 308 414 39 174 189
2023/20243.007 95 153 122 270 479 180 510 456 68 95 131 448
2024/20258.209 260 89 107 581 1.510 1.099 434 449 1.158 519 786 1.217
2025/202618.625 1.057 530 1.581 2.000 2.208 1.427 2.410 1.109 1.884 1.583 1.490 1.346
2026/20273.213 1.546 1.606 61 0 0 0 0 0 0 0 0 0
Totale 59.210